Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's disease related proteins.

Journal Information

Full Title: Mol Neurodegener

Abbreviation: Mol Neurodegener

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the appropriate Mayo Clinic Institutional Review Board. Consent for publicationNot Applicable. Competing interestsNone to report. Competing interests None to report."

Evidence found in paper:

"Funding This work was supported by National Institute on Aging [RF1 AG051504 to N.E.T and G. B, U01 AG046139 to N.E.T, and R01 AG061796 to N.E.T]. Data collection was also supported through funding by NIA grants P50AG016574, R37AG027924, Cure Alzheimer’s Fund, and support from Mayo Foundation. KN, JK, SLR and AJS were supported in part by P30 AG010133, P30 AG072976, R01 AG019771, R01 AG057739, U01 AG024904, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01 AG072177, R01 LM012535, and R01 AG069901."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025